A district judge refuses to block sales of a generic blood thinner made by Sandoz (NVS, MNTA),...

|By:, SA News Editor

A district judge refuses to block sales of a generic blood thinner made by Sandoz (NVS, MNTA), dealing Sanofi-Aventis (SNY) a serious blow in its efforts to protect best-selling blood thinner Lovenox. Good news for Teva (TEVA) though, which has a pending FDA application for a similar generic. Premarket: NVS +0.1%, MNTA +7.1%, SNY -0.8%, TEVA -1.2%.